Based on recent data, Guardant Health, Inc. (GH) shows an Average True Range (ATR) of 6.14 and an Enterprise Value of 2.42B. Its average trading volume over the past 3 months is 2.8M, indicating liquidity. These fundamental metrics provide insight into GH's underlying financial health and market activity.
| ATR | 6.14 |
| Enterprise Value | 2.42B |
| Avg Vol (3 Months) | 2.8M |
| Avg Vol (10 Days) | 2.85M |
Guardant Health, Inc. (GH) technical indicators as of July 9, 2026: the SMA 20 is -6.31%, SMA 50 at -7.5%, and SMA 200 at 32.17%. The RSI 14 value is 40.83, suggesting its current momentum. These technical analysis signals help assess GH's price trends and potential future movements.
| SMA 20 | -6.31% |
| SMA 50 | -7.5% |
| SMA 200 | 32.17% |
| RSI 14 | 40.83 |
Guardant Health, Inc. (GH) stock performance overview as of July 9, 2026: The 52-week high is $174.08 (currently -18.86% below), and the 52-week low is $40.35 (currently 180.88% above). Over the past year, GH's performance is 207.88%, compared to the S&P 500's 6.09% change.
| 52-Week High | 174.08 |
| 52-Week High Chg | -18.86% |
| 52-Week Low | 40.35 |
| 52-Week Low Chg | +180.88% |
| S&P 500 52-Week Chg | 6.09% |
According to market data, Guardant Health, Inc. (GH) stock's recent performance metrics show that over the last month, GH is 17.85%, with a Year-to-Date (YTD) performance of 12.46%. Over the past year, the stock has seen a 207.88% change. These figures summarize GH's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 174.08 | 174.08 | 174.08 | 174.08 | 174.08 | 174.08 |
| Low | 155.75 | 122.76 | 74.55 | 74.55 | 40.35 | 74.55 |
| Performance | +6.79% | +17.85% | +75.48% | +151.69% | +207.88% | +12.46% |
According to current financial data, GH stock's P/E (TTM) ratio is -46.47, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for GH, including P/S (19.34), P/B (-114.21), and P/FCF (-92.91), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | GH | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -46.47 | -1.22 | 35.41 | 32.59 |
| P/S (TTM) | 19.34 | 3.68 | 18.5 | 5.98 |
| P/B (TTM) | -114.21 | 100.67 | -5.17 | 5.13 |
| P/FCF (TTM) | -92.91 | -34.04 | -8.2 | 29.02 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep